Quest Diagnostics Incorporated
DGXNYSEHealthcare● Active
$200.29
+$4.17(+2.13%)
Market Cap$22.2B
P/E Ratio—
52W High$213.5
52W Low$164.65
Quest Diagnostics Incorporated (DGX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DGX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B |
| Cost of Revenue | $7.51B | $6.63B | $6.20B | $6.45B | $6.58B |
| Gross Profit | $3.52B | $3.24B | $3.07B | $3.43B | $4.21B |
| Gross Margin %(computed) | 31.93% | 32.86% | 33.17% | 34.74% | 39.02% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $1.92B | $1.90B | $1.81B | $2.00B | $1.83B |
| Operating Income | $1.60B | $1.35B | $1.26B | $1.43B | $2.38B |
| Operating Margin %(computed) | 14.53% | 13.63% | 13.64% | 14.45% | 22.07% |
| Interest Income | $0.00B | $0.03B | $0.01B | $0.01B | $0.00B |
| Interest Expense | $0.26B | $0.23B | $0.16B | $0.15B | $0.15B |
| Income Before Tax | $1.36B | $1.19B | $1.16B | $1.28B | $2.68B |
| Income Tax Expense | $0.31B | $0.27B | $0.25B | $0.26B | $0.60B |
| Net Income | $0.99B | $0.87B | $0.85B | $0.95B | $2.00B |
| Net Margin %(computed) | 8.99% | 8.82% | 9.23% | 9.57% | 18.49% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $8.87 | $7.80 | $7.59 | $8.12 | $15.90 |
| Wtd Avg Shares | 0.11B | 0.11B | 0.11B | 0.12B | 0.13B |
| EBITDA | $2.19B | $1.89B | $1.73B | $1.82B | $3.16B |
| EBITDA Margin %(computed) | 19.88% | 19.19% | 18.72% | 18.42% | 29.28% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Quest Diagnostics Incorporated data
About Quest Diagnostics Incorporated (DGX) Income Statement
Quest Diagnostics Incorporated (DGX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, DGX reported revenue of $11.04B, gross profit of $3.52B (gross margin 31.93%), and net income of $0.99B — a net profit margin of 8.99%.
Frequently asked questions
DGX · 4 questionsQuest Diagnostics Incorporated (DGX) reported revenue of $11.04B for 2025, up 11.8% year-over-year.
DGX revenueDGX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08